Skip to content
Smart Money

Pharmaceuticals

IBLHL IBL HealthCare Limited

Latest results: FY2026 · Jun 2026

Last close · 16 Oct 2026

Rs 41.37 -0.22%

Annual · FY2011 – FY2026

IBL HealthCare Limited (IBLHL) financial ratios

IBL HealthCare Limited earned a net margin of 4.8% in FY2026 against a five-year average of 5.2% (Pharmaceuticals median 9.4%). Return on equity was 9.1%, compared with a sector median of 21.7%. The current ratio stood at 2.30× and debt was 1.0% of equity. Cash took about 100 days to cycle through receivables, inventory and payables.

FY2026 vs the Pharmaceuticals median

Gross margin
35.7%
Sector median 37.0%
Net margin
4.8%
Sector median 9.4%
Return on equity (ROE)
9.1%
Sector median 21.7%
Return on assets (ROA)
5.5%
Sector median 11.7%
Current ratio
2.30×
Sector median 1.79×
Debt to equity
1.0%
Sector median 5.8%
Asset turnover
1.15×
Sector median 1.26×

Median of the 14 companies in the sector with the figure for their latest fiscal year.

IBLHL financial ratios (annual) (Rs mn)
Rs mn FY2026 Jul 2025 – Jun 2026 FY2025 Jul 2024 – Jun 2025 FY2024 Jul 2023 – Jun 2024 FY2023 * Jul 2022 – Jun 2023 FY2022 Jul 2021 – Jun 2022 FY2021 Jul 2020 – Jun 2021 FY2020 Jul 2019 – Jun 2020 FY2019 Jul 2018 – Jun 2019 FY2018 Jul 2017 – Jun 2018 FY2017 Jul 2016 – Jun 2017 FY2016 Jul 2015 – Jun 2016 FY2015 Jul 2014 – Jun 2015 FY2014 Jul 2013 – Jun 2014 FY2013 Jul 2012 – Jun 2013 FY2012 Jul 2011 – Jun 2012 FY2011 Jul 2010 – Jun 2011
Profitability
Gross margin 35.7% 33.5% 26.4% 33.3% 34.4% 34.0% 30.4% 28.0% 31.5% 33.4% 33.2% 38.3% 35.7% 27.2% 30.1% 27.0%
EBITDA margin — 10.5% 4.2% 15.9% 16.2% 14.9% 13.4% 13.1% 15.8% 21.8% 18.3% 21.0% 19.9% 14.7% 14.8% 10.9%
Operating margin — 10.3% 4.0% 15.7% 16.0% 14.6% 13.2% 12.9% 15.7% 21.3% 17.9% 20.4% 18.7% 13.4% 13.2% 9.3%
Pre-tax margin 8.7% 7.9% 0.8% 11.4% 13.2% 13.6% 12.1% 12.6% 15.6% 21.2% 19.1% 21.1% 19.9% 14.1% 12.1% 8.5%
Net margin 4.8% 4.8% 0.2% 7.7% 8.3% 10.0% 8.3% 7.7% 11.0% 16.7% 15.5% 17.8% 16.4% 11.6% 10.8% 7.1%
Effective tax rate 45.1% 38.8% 73.9% 32.7% 37.3% 26.6% 31.6% 39.0% 29.7% 21.4% 18.9% 15.7% 17.9% 17.3% 10.7% 15.8%
Returns
Return on equity (ROE) 9.1% 9.4% 0.4% 15.6% 17.4% 19.8% 16.4% 9.9% 13.1% 19.6% 22.4% 27.9% 32.2% 27.8% 25.5% —
Return on assets (ROA) 5.5% 5.7% 0.2% 9.5% 11.3% 12.8% 10.6% 7.4% 11.0% 15.9% 17.5% 22.5% 26.7% 18.1% 13.6% —
Return on invested capital (ROIC) 9.7% 10.6% 1.1% 15.5% 15.9% 18.4% 15.9% 9.4% 13.2% 19.7% 22.4% 27.9% 32.1% 26.1% 23.4% —
Liquidity
Current ratio 2.30× 2.02× 2.24× 2.05× 2.20× 2.27× 2.24× 2.41× 4.83× 4.47× 3.67× 3.19× 5.30× 3.32× 1.61× 1.54×
Quick ratio 1.70× 1.26× 1.49× 1.23× 1.28× 1.39× 1.46× 1.61× 3.78× 3.49× 2.60× 2.15× 2.96× 1.83× 0.79× 0.56×
Leverage
Debt to equity 1.0% 6.8% 1.1% 14.1% 14.3% 16.0% 12.6% 13.3% 0.0% — — — — 0.6% 19.3% 27.5%
Debt to capital 1.0% 6.4% 1.0% 12.4% 12.5% 13.8% 11.2% 11.8% 0.0% — — — — 0.6% 16.2% 21.5%
Debt to assets 0.7% 4.0% 0.7% 8.4% 9.1% 10.6% 7.9% 8.9% 0.0% — — — — 0.5% 10.3% 14.7%
Assets to equity 1.65× 1.65× 1.63× 1.63× 1.55× 1.55× 1.55× 1.35× 1.19× 1.23× 1.28× 1.24× 1.21× 1.53× 1.87× —
Efficiency
Asset turnover 1.15× 1.18× 1.05× 1.24× 1.36× 1.28× 1.29× 0.96× 1.00× 0.95× 1.13× 1.27× 1.63× 1.55× 1.25× —
Receivable days days 145 141 158 133 115 136 149 197 180 176 127 94 74 66 65 —
Inventory days days 133 138 145 147 129 126 115 117 88 112 111 131 113 109 165 —
Payable days days 178 165 153 128 102 109 106 106 85 109 105 91 59 90 135 —
Cash conversion cycle days 100 114 149 153 141 153 157 208 183 179 133 134 128 85 95 —
Dividends
Dividend payout ratio — 0.0% 0.0% 23.1% 21.4% 36.0% 24.6% 44.6% 32.9% 21.5% 33.7% 13.9% 15.5% 34.6% 51.0% 0.0%
Earnings retention rate — 1.00× 1.00× 0.77× 0.79× 0.64× 0.75× 0.55× 0.67× 0.78× 0.66× 0.86× 0.84× 0.65× 0.49× 1.00×

Ratios as reported for each fiscal year; returns are on average equity / assets. Debt ratios are percentages; turnover in times; working-capital measures in days.

IBLHL: frequently asked questions

What is IBLHL's EPS?

IBL HealthCare Limited reported basic earnings per share of Rs 2.24 for FY2026 (Jul 2025 – Jun 2026).

What is IBLHL's P/E ratio?

At the closing price of Rs 41.37 on 16 Oct 2026, IBLHL trades at a P/E of 18.5× based on EPS of Rs 2.24 (FY2026).

What was IBLHL's revenue and profit in FY2026?

IBL HealthCare Limited reported revenue of Rs 4.6 bn and profit attributable to shareholders of Rs 220.4 mn for FY2026 (Jul 2025 – Jun 2026).

Information only, not investment advice.